Unlocking high-yield, cost-efficient EV manufacturing through fixed-bed bioreactors
Watch the full Tech Showcase video to learn how to unlock high-yield, cost-efficient EV manufacturing through fixed-bed bioreactors. Find out how to achieve: 2- to 4-fold increased EV titer vs. flask-based systems; 6× higher viable cell density signal; 59% reduction in facility footprint compared to vertical wheel bioreactor production; 2-fold increase in protein content per EV and a 3-fold increase in the number of identified proteins; Estimated yearly cost savings of USD 0.23M to 1.7M; 64% reduction in labour costs.
Authors
- Thomas Robert (ORCID: https://orcid.org/0000-0002-7580-0913)
Publication Details
- Journal
- Cell and Gene Therapy Insights
- Published
- 2026-10-06
- DOI
- https://doi.org/10.18609/cgti.2026.116
- Primary Topic
- Viral Infectious Diseases and Gene Expression in Insects
- Type
- article
- Field-Weighted Citation Impact
- 0.00